GORE™ ImproJect™ Plungers
Eliminate silicone in both barrel and plunger to protect sensitive biologics in glass pre-filled syringes (PFS)
Contact Us
Americas
+1 800 294 4673
+1 410 506 1715
Europe
+49 89 4612 3456
+800 4612 3456
All Other Inquiries
+1 800 294 4673
+1 410 506 1715
Resource Library
Data Sheet: GORE™ ImproJect™ Plungers
Data Sheets, 411.03 KB
GORE™ ImproJect™ Plungers eliminate the need for silicone as a lubricant in pre-filled syringes. Used with bare-glass (non-siliconized) barrels, these silicone-free plungers provide consistent delivery performance over time, and can protect complex or sensitive biologics from silicone-induced aggregation and particulation.
English (U.S.)
All Resources For GORE™ ImproJect™ Plungers
- Data Sheets (1)
- Validation Guides (1)
Overview
Eliminate silicone in both barrel and plunger to protect sensitive biologics in glass pre-filled syringes (PFS)
Today’s complex biologics, such as monoclonal antibodies and conjugate vaccines, can be vulnerable to silicone-induced protein aggregation and particle formation. In addition, over time, silicone migration can impact consistency of delivery, as it may change break loose and glide force (BLGF) and injection time. As a result, many biopharmaceutical manufacturers are actively seeking ways to address these silicone-related issues.
Now, GORE™ ImproJect™ Plungers Offer A New Solution
For the first time, GORE™ ImproJect™ Plungers enable manufacturers to completely eliminate silicone from both plunger and barrel in their PFS.
New GORE™ ImproJect™ Plungers for pre-filled syringes protect complex and sensitive biologics from silicone-induced protein aggregation and particulation. They do so by completely eliminating the need for silicone in both the plunger and the glass barrel.
- The plungers are silicone-free: Silicone is not a raw material and is not used in the manufacture of the plungers.
- The plungers, designed for use in bare-glass (non-siliconized) barrels, provide excellent container closure integrity (CCI) and maintain consistent injection performance over time.
Exceptionally Low Particles
GORE™ ImproJect™ Plungers effectively protect many of the more complex biologics that are silicone-sensitive. Testing demonstrates that GORE™ ImproJect™ Plungers provide:
- Orders of magnitude reduction in sub-visible particles, compared to siliconized syringes.
- Excellent biocompatibility: 21 CFR Part 4 and ISO 10993-1.
- No significant extractable compounds, due to our plunger’s proprietary PTFE-based fluoropolymer barrier.
Functional Performance
The only plunger that enables low particulates and consistent delivery over time in bare glass (non-siliconized) barrels.
Due to its proprietary plunger design and fluoropolymer barrier, the GORE™ ImproJect ™ Plunger ensures:
- Excellent CCI, to protect against drug loss, leakage and microbial ingress.
- Consistent delivery including auto-injector applications – even after accelerated aging conditions.
- No significant extractable compounds.
A New Option for Drug Delivery
GORE™ ImproJect™ Plungers provide the only option for a silicone-free PFS (plunger with glass barrel), which protects sensitive biologics from potential interactions with silicone. To explore this new option in drug delivery, connect with your local Gore representative, or contact us.
Compliance & Quality
GORE™ ImproJect™ Plungers are manufactured in accordance with appropriate material and regulatory requirements, including USP <381>, EP 3.2.9 ad JP7.03, and in adherence to relevant Good Manufacturing Processes (cGMP) as defined in the Gore PharmBIO quality system, which is certified to ISO 13485, and ISO 15378.
To read our most current compliance statements, please contact us.
Product Information
For additional product information, please review our Data Sheet. To request a technical consultation, product samples, or a Validation Guide, please contact us.
Resources
Data Sheet: GORE™ ImproJect™ Plungers
Data Sheets, 411.03 KB
Validation Guide: GORE™ ImproJect™ Plungers
Validation Guides
Recent News
Event
GORE PharmBIO’s Rob Gelissen to Speak at the 12th Global Drug Delivery & Formulation Virtual Summit 2021
March 15, 2021 - March 17, 2021
Join GORE PharmBIO’s Rob Gelissen, Business Development representative for Drug Delivery and Packaging for W.L. Gore & Associates’ PharmBIO Division on March as he presents “Silicone-Free Prefilled Syringe Packages for Sensitive Biologics and Ophthalmic injections.”
Press Release
ViaCyte and Gore Enter Clinical Phase Agreement Based on Novel Membrane Technology for PEC-Encap Product Candidate
Posted August 5, 2020
Clinical evaluation of PEC-Encap has resumed using sentinels created with the novel membrane; preclinical and initial clinical data suggest the novel membrane can mitigate the foreign body host response.
Press Release
GORE® STA-PURE Flexible Freeze Container Receives Medicine Maker Innovation Award
Posted April 12, 2020
GORE® STA-PURE Flexible Freeze Containers' patented design was engineered to maximize container strength while the high-purity, biocompatible fluoropolymer composite film was selected for its durability and low extractables profile. The choice of Gore as one of the winners was based on it's potential impact on the industry. Drug manufacturers now have a high purity option for bulk drug storage that won't become brittle and potentially break or leak in use.
Press Release
Gore introduces new 9.0mL Protein Capture Device for affinity chromatography
Posted March 20, 2020
Gore is adding to it's range of affinity chromatography devices with the larger 9.0 mL size device for applications in process development, pre-clinical and early clinical drug development. This launch is significant because it demonstrates that this innovative membrane technology can be scaled to larger sizes without losing performance benefits.
Follow GORE™ ImproJect™ Plungers